Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events: Implications for Prevention.

Biases in detection of apparent "weekend effect" on outcome with administrative coding data: population based study of stroke. BMJ (2016) 1.45

Baseline Characteristics of a Retrospective Patient Cohort in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry. Korean Circ J (2017) 0.75

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ (2002) 20.22

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg (2007) 14.17

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J (2012) 13.74

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69

Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65

Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62

Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg (1997) 5.88

Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet (2005) 5.38

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.27

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol (1991) 4.67

A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med (1998) 3.58

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry (1991) 2.49

Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation (1997) 2.29

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol (1996) 2.25

Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart (2014) 2.09

Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg (2007) 2.08

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg (2011) 1.64

Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg (1994) 1.62

Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol (2010) 1.58

The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol (1996) 1.56

Reprinted article "The fate of the claudicant--a prospective study of 1969 claudicants". Eur J Vasc Endovasc Surg (2011) 1.39

Fatal nonocclusive mesenteric ischaemia: population-based incidence and risk factors. J Intern Med (2006) 1.35

Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 1.28

Intermittent claudication: prevalence and risk factors. Br Med J (1978) 1.23

Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand (1982) 1.21

Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg (2006) 1.16

Incidence of acute thrombo-embolic occlusion of the superior mesenteric artery--a population-based study. Eur J Vasc Endovasc Surg (2004) 1.13

Critical limb ischaemia: management and outcome. Report of a national survey. The Vascular Surgical Society of Great Britain and Ireland. Eur J Vasc Endovasc Surg (1995) 1.11

A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann Surg (2003) 1.10

Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial. Health Technol Assess (2010) 1.08

Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J (1994) 1.03

Lower limb amputations in Southern Finland in 2000 and trends up to 2001. Eur J Vasc Endovasc Surg (2004) 0.98

National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): clinical factors associated with early outcome. J Vasc Surg (2004) 0.95

Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol (1994) 0.88

Peripheral arterial disease: a high risk - but neglected - disease population. BMC Cardiovasc Disord (2005) 0.87

Epidemiology of critical limb ischaemia: north Italian data. Eur J Med (1993) 0.86

Arterial intervention and reduction in amputation for chronic critical leg ischaemia. Br J Surg (2000) 0.85

Intermittent claudication--epidemiology and natural history. Acta Cardiol (1979) 0.83

Open versus endovascular intervention for critical limb ischemia: a population-based study. J Am Coll Surg (2010) 0.80

Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation. Int Angiol (1993) 0.80

Why patients know more about cars than peripheral artery disease. Circulation (2014) 0.78

[Major and minor amputation rates and lower critical limb ischemia: the epidemiological data of western Tuscany]. Ital Heart J Suppl (2004) 0.77

Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet (2004) 7.33

Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet (2005) 5.38

Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ (2004) 3.47

Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study. Lancet Neurol (2010) 2.33

Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol (2007) 2.02

Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol (2015) 1.70

Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurol (2012) 1.61

Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study. Circulation (2014) 1.53

Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation (2013) 1.53

Biases in detection of apparent "weekend effect" on outcome with administrative coding data: population based study of stroke. BMJ (2016) 1.45

Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study. Neurology (2015) 1.42

ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack. Stroke (2010) 1.37

A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke. Stroke (2012) 1.15

Population-based study of behavior immediately after transient ischemic attack and minor stroke in 1000 consecutive patients: lessons for public education. Stroke (2010) 1.14

Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study. Neurology (2013) 1.08

Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study. Stroke (2013) 1.07

Population-based study of risk and predictors of stroke in the first few hours after a TIA. Neurology (2009) 0.96

Sustained impact of UK FAST-test public education on response to stroke: a population-based time-series study. Int J Stroke (2015) 0.88

Time Course of Evolution of Disability and Cause-Specific Mortality After Ischemic Stroke: Implications for Trial Design. J Am Heart Assoc (2017) 0.88

Methodological factors in determining rates of dementia in transient ischemic attack and stroke: (I) impact of baseline selection bias. Stroke (2015) 0.83

Hemodynamic correlates of transient cognitive impairment after transient ischemic attack and minor stroke: A transcranial Doppler study. Int J Stroke (2016) 0.81

Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet (2017) 0.81

Methodological Factors in Determining Risk of Dementia After Transient Ischemic Attack and Stroke: (III) Applicability of Cognitive Tests. Stroke (2015) 0.80

Methodological Factors in Determining Risk of Dementia After Transient Ischemic Attack and Stroke: (II) Effect of Attrition on Follow-Up. Stroke (2015) 0.79

Age-specific incidence, risk factors and outcome of acute abdominal aortic aneurysms in a defined population. Br J Surg (2015) 0.79

Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study. J Neurol Neurosurg Psychiatry (2015) 0.75

Population-Based Study of Incidence of Acute Abdominal Aortic Aneurysms With Projected Impact of Screening Strategy. J Am Heart Assoc (2015) 0.75

White Matter Imaging Correlates of Early Cognitive Impairment Detected by the Montreal Cognitive Assessment After Transient Ischemic Attack and Minor Stroke. Stroke (2017) 0.75

Etiological Subtypes of Transient Ischemic Attack and Ischemic Stroke in Chronic Kidney Disease: Population-Based Study. Stroke (2020) 0.75

Time-of-Day Could Affect Cognitive Screening Performance in Older Patients with TIA and Stroke. Cerebrovasc Dis (2017) 0.75

Confounding by Pre-Morbid Functional Status in Studies of Apparent Sex Differences in Severity and Outcome of Stroke. Stroke (2017) 0.75